How will nanotechnology lead to better control of asthma?

  • Yang B
  • Choi H
  • Kim S
  • et al.
N/ACitations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

Asthma is a common inflammatory disease of the lungs characterized by reversible airway obstruction, bronchial hyper-responsiveness, and chronic airway inflammation (1). The most widely used therapies for asthma include inhaled corticosteroids and bronchodilators (short- or long-acting β 2 -adrenergic agonists or muscarinic antagonists). Although most patients with asthma respond well to inhaled corticosteroids, asthma control is poor in some patients who require maximal dosages (2).

Cite

CITATION STYLE

APA

Yang, B., Choi, H., Kim, S.-H., Yoon, H. J., & Lee, H. (2019). How will nanotechnology lead to better control of asthma? Annals of Translational Medicine, 7(20), 515–515. https://doi.org/10.21037/atm.2019.09.129

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free